Management of complex esophageal problems in children is challenging. We report our experience with the use of esophageal stents in three children with esophageal strictures, leaks, or airway-esophageal fistulae refractory to conventional treatment. The stent played a key role in allowing extubation of a child with a large tracheo-esophageal-pleural fistula and in the resolution of pulmonary infection in a child with esophago-bronchial fistula, both followed by surgery. In the third child, with stricture, stents were complicated with migration, esophageal erosion, and esophago-bronchial fistula. In our experience, esophageal stents were useful mainly as a bridge to definitive surgical repair.
Introduction
Although the use of esophageal stents has been relatively common in adults, [1, 2] for both benign and malignant conditions, their use in children is still evolving. [3] [4] [5] [6] [7] [8] [9] [10] [11] There are a few reports on the use of covered stents in children with caustic strictures or strictures after esophageal atresia repair in which dilatations were unsuccessful. [3, 6, 10] In regards to leak or perforation after repair of esophageal atresia or esophageal dilatations, nonoperative management is usually effective. However, there are some cases in which the esophagus fails to close with nonoperative management in which covered stents could be used to manage such perforations. [5, 7] Small size of the pediatric esophagus and the lack of availability of dedicated pediatric esophageal stents [ Table 1 ] makes this process difficult. This report describes the application of esophageal stents in children with esophageal strictures, leaks, or airway-esophageal fistulae refractory to conventional treatment at a tertiary care children's hospital.
Case Series
Three children aged 7 months, 1 year, and 4 years underwent esophageal stenting at a tertiary care pediatric hospital between December 2012 and November 2016. Institutional review board approval was obtained for this retrospective review.
The stents used in this series were covered nitinol esophageal (Alimaxx-ES™) or tracheo-bronchial (AERO ® ) commercially available stents (Merit Medical Systems, Inc., South Jordan, UT, USA). The features of the stent include polyurethane coating to decrease granulation tissue formation, anti-migration struts to decrease migration, and a proximal suture knot to aid removal. All stents were placed in the interventional radiology suite under general anesthesia with flexible endoscopy and fluoroscopy guidance using a flexible over-the-wire delivery system. The esophageal diameter was estimated using previous contrast study and endoscopic assessment, and the stent diameter was oversized by approximately 2 mm. The length of the stent was selected to provide at least 2 cm overlap on either side of the leak but without extension into the upper or lower gastrointestinal sphincter. After stent deployment, an esophagogram was performed to document stent position and absence of extravasation. Follow-up chest radiographs were performed as needed during follow-up.
Case 1
A 1-year-old boy developed a large acquired tracheo-esophageal fistula [ Figure 1A ] after endoscopic removal of a swallowed foreign body. This was surgically repaired but complicated postoperatively with leak from the esophageal anastomosis and tracheo-esophago-pleural fistula. This led to tension pneumothorax for which multiple chest tubes were placed. The patient however continued to have difficulty with ventilation and could not be extubated. A 12 mm × 7 cm Alimaxx-ES™ stent was placed in the esophagus [ Figure 1B ] to exclude the large fistula. This allowed the patient to be weaned off the ventilator and extubated on postoperative day 8. On postoperative day 15, however, the stent migrated proximally [ Figure 1C ] and was removed. Thereafter, the patient had successful surgical repair of the partially healed fistula.
Case 2
A 4-year-old boy had congenital esophageal atresia and distal tracheo-esophageal fistula repaired at an outside hospital.
Investigation of recurrent pneumonia led to the finding of an acquired esophago-bronchial fistula [ Figure 2A ]. An Amplatzer™ Vascular Plug II (St. Jude Medical, St.Paul, MN, USA) was placed within the fistula along with a 16 mm × 7 cm Alimaxx-ES™ esophageal stent [ Figure 2B ] to completely exclude the fistula. The stent was removed electively at 8 weeks and esophagogram immediately post removal was normal. However, a repeat study two weeks later prior to initiation of oral feeding showed persistent fistula. During this period, the patient had improved symptomatically and all signs of infection had cleared. The patient underwent successful surgical repair with no recurrence of the fistula at the 3-year follow-up.
Case 3
A 7-month-old girl with Trisomy 21, long-gap esophageal atresia, duodenal atresia, and Hirschprung's disease underwent delayed primary esophageal anastomosis at 4 months of age during which the esophageal ends were tacked together without fashioning an anastomosis because of excessive tension. One month later, the ends of the esophagus were reapproximated over a trans-anastomotic tube. This was complicated by contained leak and anastomotic stricture that did not respond to repeated dilatations [ Figure 3A ]. A 12 mm × 4 cm AERO ® tracheo-bronchial stent was placed across the stricture and leak [ Figure 3B ]. The AERO ® stent was selected because the shortest available Alimaxx-ES™ esophageal stent was 7 cm that would have extended into the stomach. Distal migration of the AERO ® stent after one week was managed with telescoping a 14 mm × 4 cm AERO ® stent within the previous stent. Over the ensuing 4 weeks, the coaxial stents not only migrated distally but also eroded into the right lateral esophageal wall creating a large diverticulum [ Figure 3C ]. This made removal of the stent challenging by obscuring a large part of the upper border of the stent and its suture knot. Over the following 2 weeks, the diverticulum progressed to a esophago-bronchial fistula and there was recurrence of the stricture. The patient was not a candidate for colon interposition given Hirschprung's disease and had frozen chest from repeated thoracotomies and soiling, therefore, a proximal esophageal diversion was performed. The patient, however, succumbed to progressive respiratory deterioration and aspiration pneumonia from the persistent esophago-bronchial fistula.
Discussion
Esophageal leaks and strictures in children can occur after a variety of procedures including repair of esophageal atresia, dilatation of stricture, or ingestion of caustic agents. Esophageal anastomotic leaks and iatrogenic esophageal perforations often heal over time with nonoperative management. However, the management of complex esophageal problems that do not heal spontaneously or respond to dilatations is challenging.
The use of esophageal stents in children is evolving and has mostly been described for treatment of strictures refractory to dilatation. [3, 4, 6, 10, 12] The advent of covered retrievable stents led to their utilization particularly for caustic strictures as well as for strictures following esophageal atresia repair with high success rates. Zhang et al. described eight patients with corrosive esophageal stenosis who underwent placement of covered retrievable nitinol stents. [3] All patients were able to eat solid food without dysphagia after stent removal. Rollins et al. reported a series of three patients with persistent esophageal leaks in which covered nitinol stents were successfully used, [5] and patients were able to receive nutrition orally with the stents in place. They concluded that the use of esophageal stents should be considered as an effective option for these cases. In a large pediatric experience of esophageal stenting, Manfredi et al. concluded that esophageal stents proved more useful in the management of esophageal perforations than recalcitrant anastomotic strictures. [8] In the current report, esophageal stents were useful mainly as a bridge to definitive surgical repair. In case 1, the stent played a critical role in controlling massive leak of tidal volume through the tracheo-esophago-pleural fistula. This made it possible to extubate the child but the stent migrated prematurely and required surgical management of the residual fistula. In case 2, the stent temporarily sealed the esophago-bronchial fistula allowing the child to recover from severe pneumonia and systemic illness. The child was then a better candidate for surgical repair. In both these cases, however, the stent could only provide partial or temporary healing of the perforation and surgical repair was subsequently required.
One of the main complications of esophageal stents is stent migration. Migration has been reported in 0-29% of pediatric patients [12] and 30-60% in the adult literature. [4] The Alimaxx-ES™ esophageal and AERO ® tracheo-bronchial stents have anti-migration struts that are designed to decrease the risk of migration. The struts are oriented such that they counter distal migration of the esophageal stent and proximal migration of the tracheo-bronchial stent. It has also been reported that stents placed in the upper and lower esophagus are more likely to migrate and more difficult to manage. [13] Stent migration was a significant problem in case 1 and case 3 in the current series. In case 1, although an esophageal stent with distal anti-migration struts was used, placement in the upper esophagus in proximity to the cricopharyngeal sphincter was most likely responsible for its early proximal migration. In case 3, distal migration occurred despite stent revision. In this patient, a 4-cm long AERO ® tracheo-bronchial stent was placed initially because the commercially available esophageal stents were too long for this 7-month-old child. The tracheo-bronchial stents have struts oriented to prevent proximal migration, but do not prevent distal migration. In addition, a high-grade anastomotic stricture with a tortuous lumen in this child also contributed to stent migration.
Esophageal perforation secondary to esophageal stents has been reported as one of the delayed complications. [14] [15] [16] Manfredi et al. reported esophageal perforation and migration of an esophageal stent into the pleural space within two weeks of placement and recommended close monitoring of all children undergoing esophageal stenting. [8] In case 3, angulation of the rigid AERO ® stent into the right lateral wall of the esophagus resulted in erosion of the esophagus and formation of a large diverticulum which subsequently progressed to esophago-bronchial fistula. The AERO ® stent is made from a laser cut solid nitinol tube which makes its structure rigid, straightens the natural esophageal curves, and causes pressure necrosis of the esophageal wall.
Esophageal stenting in children presents several technical challenges. In infants and smaller sized children, the commercially available esophageal stents may be too long. In these patients, AERO ® tracheo-bronchial stents available in shorter lengths may be utilized cautiously. The size mismatch and rigidity of the stents also makes the esophagus vulnerable to pressure necrosis, for which close monitoring and timely removal is suggested. There is certainly a need for development of smaller sizes (both length and diameter) of stents as well as more flexible stents which conform to the natural curvatures of the pediatric esophagus.
In conclusion, esophageal stents may serve as a useful tool in the management of children with esophageal leaks and acquired airway-esophageal fistulae refractory to conventional treatment. In this case series, the stent allowed for time to control ventilation and resolve infection, acting as a bridge to definitive surgical repair. The small size and tortuosity of the pediatric esophagus and the limited availability of commercial esophageal stents designed for the pediatric esophagus are challenges in this field. Development of esophageal stents with improved flexibility, anti-migration features and smaller diameters and lengths could further increase their successful application in children.
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